Approval of the revised protocol with modifications including use of local labs for blood work, changes to the minimum and maximum number of patients enrolled per site, and a revised study timeline for the post-approval study (pas) protocol.
Device | AspireAssist |
Classification Name | Aspiration Therapy System |
Generic Name | Aspiration Therapy System |
Applicant | ASPIRE BARIATRICS INC |
Date Received | 2018-05-01 |
Decision Date | 2019-01-15 |
PMA | P150024 |
Supplement | S010 |
Product Code | OYF |
Advisory Committee | Gastroenterology/Urology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | ASPIRE BARIATRICS INC 3200 Horizon Drive suite 100 king Of Prussia, PA 19406 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P150024 | | Original Filing |
S016 |
2019-10-29 |
Normal 180 Day Track No User Fee |
S015 | | |
S014 | | |
S013 | | |
S012 |
2018-09-25 |
Special (immediate Track) |
S011 |
2018-05-22 |
Special (immediate Track) |
S010 |
2018-05-01 |
Normal 180 Day Track No User Fee |
S009 |
2018-02-07 |
Special (immediate Track) |
S008 |
2018-01-19 |
Normal 180 Day Track |
S007 | | |
S006 |
2017-03-27 |
Real-time Process |
S005 |
2016-10-17 |
Normal 180 Day Track No User Fee |
S004 |
2016-08-16 |
Real-time Process |
S003 |
2016-08-15 |
Special (immediate Track) |
S002 | | |
S001 |
2016-07-29 |
Special (immediate Track) |
NIH GUDID Devices